Professional Documents
Culture Documents
Materials:
Adverse reaction to IV Contrast Media and
Medication LESSON REVIEW/PREVIEW (10 minutes)
Book, pen and notebook, index card/class list
After the instructor give a brief overview on Introduction in Pharmacology and Venipuncture, it`s time to assess the
student`s understanding through answering the following questions:
Phlebotomy – is taken from the Greek word “Phleb” means referring a vessel” and “tomy” means to make an
incision) The procedure is known as a venipuncture which is the process of performing an incision or making a cut
or wound using a sharp object. Phlebotomist is called to the person has the title, who performs phlebotomy but in
many countries doctors and nurses do of some work of phlebotomy procedures.
Phlebotomists | Phlebotomy Technician a collector of blood samples is their primary function by making an
incision to patients by means of venipuncture or mirotechniques. Venipuncture is a puncture to a vein for
widrawal of blood and administering drug or radiopaque dye used for radiographic purposes.
Venipuncture
Sites
Position the patient so that the vein is easily accessible and you are able to
perform the venipuncture in a comfortable position. Always have the patient
either
lying in bed or sitting in a chair with the arm
propped up.
3. Position the patient’s arm extended with little or no flexion at the elbow.
4. Locate a prominent vein by palpation (feeling). If the vein is difficult to find, it may be made more prominent by
massaging the arm with an upward motion to force blood into the vein.
5. Cleanse the puncture site with a 70% alcohol pad or povidoneiodine solution and allow to dry.
6. “Fix” or hold the vein taut. This is best accomplished by placing the thumb under the puncture site and exerting a
slight downward pressure on the skin or placing the thumb to the side of the site and pulling the skin taut laterally.
7. Using a smooth continuous motion, introduce the needle, bevel side up, into the
side of the vein at about a 15degree angle with the skin.
8. Hold the one hand and release the tourniquet with the
other.
9. Place a sterile gauze over the puncture site and remove the needle with a quick,
smooth motion.
10. Apply pressure to the puncture site and instruct the patient to keep the arm in a
straight position. Have the patient hold pressure for at least 3
minutes.
11. Re-inspect the puncture site to make sure bleeding has stopped, and apply a
bandage.
This document and the information thereon is the property 3 of 7
of Luna Goco Colleges, Inc.
Intravenous Radiocontrast Media: A Review of Allergic Reactions
Intravenous radiocontrast, or IV dye, is used for many different diagnostic procedures to enhance the images in
various radiologic studies. Examples of studies include computed tomography (CT) scans, angiograms, and
Pyelogram. These diagnostic procedures are done on a daily basis in hospital interventional radiology and
cardiology departments around the world. In general, they are used to enhance the visibility of blood vessels.
There are two basic types of contrast media that are used for most radiologic studies: ionic high-osmolality contrast
media and non-ionic low-osmolality contrast media. The latter has become the preferred form of IV dye in recent
years, given its better safety record, especially for women who are breastfeeding. However, it is far more
expensive than high-osmolality contrast media. Allergy reactions to IV dye are common, can range from mild to
moderate, and can sometimes be life
threatening.
It is believed that people who have an allergy to seafood (shellfish) may show an allergy to contrast media as well,
due to the presence of iodine in both. We will briefly review the types, applications, and allergy profile of these
products in this article.
Both high-osmolar contrast media (ionic) and low-osmolar contrast media (nonionic or organic) agents contain
iodine and are administered intravenously. Most intravascular contrast media are derivatives of tri-iodobenzoic
acid. The iodine molecule is an effective x-ray absorber in the energy range where most clinical systems operate.
Iodinated contrast media are the most efficient products to enhance the visibility of vascular structures and organs
during radiographic procedures. The ionic type creates more charged particles and causes a high osmolality in
blood, which may cause a potentially life threatening contrast media reaction in some individuals with medical
conditions. The nonionic agents generate less dissociation and particles and decrease this risk, but are much more
expensive. The nonionic contrast media are much more widely used today. The iodine concentration of contrast
media is determined by the number of iodine molecules in milligrams present in a milliliter of a solution (mg/mL).
Concentration of any contrast media agent determines how radiopaque the agent will be. The higher the iodine
concentration, the better the chance that more x-ray photons will be absorbed. Therefore, that particular contrast
agent may be more radiopaque than a comparable low-iodine concentrated agent.
The osmolality of a solution is the measurement of the number of molecules and particles in a solution per kilogram
of water. In other words, osmolality can be described as a measurement of the number of molecules that can crowd
out or displace water molecules in a kilogram of water. The radiographic significance of the osmolality value of
contrast media is that it is
higher than the osmolality value of blood plasma. Any solution that has an osmolality value greater than blood
plasma is said to be a hyperosmolar solution. Therefore, ionic and nonionic contrast media are hyperosmolar
solutions when compared to blood plasma.
Since certain radiographic procedures, such as myelography, cannot use ionic contrast media, the discovery of
nonionic contrast media in 1974 (e.g., metrizamide) revolutionized these procedures.
Optison is used in patients with suboptimal echocardiograms to opacify the left ventricle and to improve the
delineation of the left ventricular endocardial borders.
Omnipaque is used for angiocardiography; aortography including studies of the aortic root, aortic arch, ascending
aorta, and abdominal aorta and its branches; contrast enhancement for CT scan of head and body imaging; IV
digital subtraction angiography (DSA) of the head, neck, abdominal, renal, and peripheral vessels; peripheral
arteriography; and excretory urography.
Nonionic or organically bound iodine contrast media such as Visipaque (270 mgI/mL) are used for DSA. Visipaque
Injection (320 mgI/mL) is used for angiocardiography, peripheral arteriography, visceral arteriography, and cerebral
arteriography.
This document and the information thereon is the property 4 of 7
of Luna Goco Colleges, Inc.
Visipaque Injection (270 mgI/mL and 320 mgI/mL) is indicated for CT of the head and body (excretory urography).
Visipaque Injection (270 mgI/mL) is also indicated for peripheral venography. Another example of the nonionics is
Isovue-300 (iopamidol), which is used to help diagnose certain disorders of the heart, brain, blood vessels, and
nervous system.
The rate or speed of contrast media injections may increase the risk of an adverse reaction. Also, the viscosity or
thickness of the contrast media can cause resistance to its flow. The viscosity is related to the concentration, the
size of the molecules in a specific contrast agent, and the temperature of the contrast agent. Contrast media with
higher viscosity values should be injected at a slower rate. Heating the contrast media, usually to body
temperature, reduces viscosity. Iodine concentration, viscosity, temperature of the contrast media, catheter inner
diameter, catheter length, and the number of catheter holes are all factors that influence contrast media flow.
Allergies
In most cases, shortly after infusion, iodinated contrast media cause a warming sensation throughout the body. In
certain areas of the body this feeling is more pronounced. Patients receiving contrast media via IV typically
experience a hot feeling around the throat, and this hot sensation gradually moves down to the pelvic area.
Reactions to IV dye are observed in 5% to 8% of patients who receive them. Mild reactions include a feeling of
warmth, nausea, and vomiting. Generally, these symptoms occur only for a short period of time and do not require
treatment. Moderate reactions, including severe vomiting, hives, and swelling, occur in 1% of patients receiving
contrast media and frequently require treatment. Severe, life-threatening reactions, including anaphylaxis, occur in
0.1% of people receiving contrast media, with an expected death rate of one person in every 75,000. The most
severe reactions, including death, have been reported to occur at similar rates with both types of contrast media.
Reactions to contrast media are not a true allergy, but rather a pseudoallergy in nature, meaning that there is no
allergic antibody present that causes the reaction. Rather, contrast media act to directly release histamine and
other chemicals from mast cells. The iodine concentration has an effect on the severity of an adverse reaction. The
higher the iodine concentration, the greater the risk of an adverse reaction.
Iodinated contrast media are toxic to the kidneys and kidney functions. The serum creatinine of the patient
receiving a dose should be monitored before the procedure. In addition, the estimated glomerular filtration rate
(eGFR) should be no lower than 30 mL/min in patients receiving iodinated contrast, and discretion should be used
in patients with eGFR less than 45 mL/min. Following injections with extra fluids is highly recommended.
Numerous studies have shown that although iodine is common in contrast media, iodine is not the cause of allergic
reactions. Certain proteins in seafood, rather, are the cause of allergy in patients with seafood allergies. It is noted
that true allergic effects are by definition immunoglobulin E–related, and studies have shown that contrast media
cause no such reaction in vivo. Therefore, contrast media or the iodine is not likely to act as an allergen.
Contrast media reactions can be prevented by a test dose for the intended contrast or the use of an alternative; the
use of nonionic versus ionic media if applicable; and the use of certain medicines prior to the administration of
contrast media such as prednisone 50 mg orally taken at 13, 7, and 1 hour prior to procedure, or diphenhydramine
(Benadryl) 50 mg orally, IV or intramuscularly, 1 hour prior to receiving radiocontrast media.
Risk Factors
As mentioned above, people who have seafood allergy are not at risk if they need to use contrast media. In
addition, people with an allergy to topical iodine cleaners or iodides are also not at increased risk for reactions to
contrast media. Patients who are at higher risk include those with past reactions to contrast media (up to 44%);
those with asthma; those who have a history of heart and kidney and thyroid (both hypo- and hyperthyroidism)
diseases; those taking beta-blockers or metformin; and females and the elderly (appear to be at higher risk for
severe reactions).
Note: Timely follow-up of serum creatinine levels in patients with diabetes who are receiving metformin therapy is
highly important, and monitoring is required by pharmacists. Nearly 4% of patients with diabetes mellitus and
normal renal function may develop contrast material–associated neuropathy with nonionic contrast media. Roughly
8% of patients with diabetes receiving metformin, whose baseline serum creatinine levels are below 1.5 mg/dL,
develop an increased risk of lactic acidosis requiring metformin therapy to be withheld for at least 48 hours after
administration of IV contrast material. The FDA currently recommends metformin monitoring in patients who are
undergoing radiologic procedures involving administration of IV contrast media.
Discontinuing an IV infusion:
(Teacher creates a short quiz for students to check how well they understood the lesson)
(Check for Understanding may also be a summative test which the teacher will check and grade)
Multiple Choice
(For 1-10 items, please refer to the questions in the Rationalization Activity)
2. It is used in patients with suboptimal echocardiograms to opacify the left ventricle and to improve the
delineation of the left ventricular endocardial borders
A. Omnipaque
B. Optison
C. Visipaque
D. Non-ionic
Answer: ____
___________________________________________________________________________________________
______ _________________________________________________________________________________
3. These are a type of medical contrast medium used to improve the visibility of internal bodily structures in
X-ray based imaging techniques such as computed tomography (CT), radiography, and fluoroscopy.
A. Dye
B. Radiocontrast agents
C. Intravenous Radiographic contrast
D. AOTA
Answer: ____
___________________________________________________________________________________________
______ _________________________________________________________________________________
4. Any solution that has an osmolality value greater than blood plasma is said to
be____________ A. hyperosmolar solution
B. hypoosmolar solution
C. radiographic solution
D. NOTA
Answer: ____
___________________________________________________________________________________________
______ _________________________________________________________________________________
5. It described as a measurement of the number of molecules that can crowd out or displace water molecules in
a kilogram of water.
A. ionic concentration
B. non-ionic compounds
C. osmolality of a solutions
D. hyperosmolar solution
Answer: ___
___________________________________________________________________________________________
______ _________________________________________________________________________________